Omega Therapeutics, Inc.
NASDAQ:OMGA
1.33 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -97.428 | -102.701 | -68.28 | -29.447 | -17.945 |
| Depreciation & Amortization
| 6.771 | 5.19 | 1.387 | 1.146 | 0.794 |
| Deferred Income Tax
| 1.875 | 0 | 1.332 | 0.025 | -0.003 |
| Stock Based Compensation
| 8.793 | 7.753 | 3.184 | 0.637 | 0.335 |
| Change In Working Capital
| -9.366 | -9.882 | 4.662 | 1.565 | 1.181 |
| Accounts Receivables
| -5.513 | -0.362 | -0.257 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.487 | 0.985 | 1.04 | 0.138 | 0.671 |
| Other Working Capital
| -2.366 | -10.505 | 3.879 | 1.427 | 0.51 |
| Other Non Cash Items
| -2.155 | 1.125 | 0.106 | -0.059 | -0.041 |
| Operating Cash Flow
| -91.51 | -98.515 | -57.609 | -26.133 | -15.679 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -2.869 | -1.38 | -1.467 | -1.808 | -0.885 |
| Acquisitions Net
| 0.65 | 16.68 | 0 | 0 | 0 |
| Purchases Of Investments
| -19.768 | -57.415 | -38.932 | 0 | 0 |
| Sales Maturities Of Investments
| 69.502 | 40.735 | 0 | 0 | 0 |
| Other Investing Activites
| 50.384 | -16.68 | -38.932 | 0 | 0 |
| Investing Cash Flow
| 47.515 | -18.06 | -40.399 | -1.808 | -0.885 |
| Financing Activities: | |||||
| Debt Repayment
| -1.608 | 0 | -8 | 0 | -3.985 |
| Common Stock Issued
| 40.215 | 0.708 | 131.238 | 48.618 | 8 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.288 | 0.708 | 130.301 | -0.083 | 7.97 |
| Financing Cash Flow
| 41.823 | 0.708 | 261.539 | 48.618 | 11.985 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -2.172 | -115.867 | 163.531 | 20.677 | -4.579 |
| Cash At End Of Period
| 68.443 | 70.956 | 186.823 | 23.292 | 2.615 |